相关实验视频

Updated: Jun 5, 2025

Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS

Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS

Published on: April 18, 2018

贝达基林单疗法用于多胞性麻风病

Jaison Barreto¹, Patricia Sammarco Rosa¹, Linda Adams¹

¹From the Research Division, Instituto Lauro de Souza Lima, Bauru (J.B., P.S.R.), and Fundação de Dermatologia Tropical e Venereologia Alfredo da Matta, Manaus (P.F.B.R.) - both in Brazil; the Department of Health and Human Services, Health Resources and Services Administration, Health Systems Bureau, National Hansen's Disease Program, Laboratory Research Branch, Baton Rouge, LA (L.A., R.T.); Translational Medicine and Early Development Statistics (S.Y.), WAVE Team (Z.A., S.R.C., S.K., D.M., J.A.P., M.W.), Janssen Research and Development, San Diego, CA; Janssen Global Public Health, Janssen Research and Development, Titusville, NJ (N.B., R.D.A.); and Janssen Global Public Health, Janssen Pharmaceutica, Beerse, Belgium (E.E., N.L., B.R.).

The New England journal of medicine

|December 12, 2024

概括

贝达基林单一疗法在4周内有效清除了麻风病患者的Mycobacterium leprae,并在7周内改善了皮肤病变,为标准多药疗法提供了潜在的更安全的替代方案.

科学领域:

传染性疾病传染性疾病
皮肤病学皮肤病学
药理学药理学是指药理学的学科.

背景情况:

治疗麻风的标准多药疗法 (MDT) 可以引起严重的副作用,加剧耻辱感.
耐药性麻风需要新的治疗策略和更安全的治疗方案.
替代药物组合对于有效的麻风管理至关重要.

研究的目的:

为了评估贝达基林单一治疗在以前未经治疗的多细菌性麻风患者中的疗效和安全性.
评估贝达基林对Mycobacterium leprae活力和临床症状的影响.
探索贝达基林作为更短,更安全的麻风治疗方案的潜在组成部分.

主要方法:

巴西的开放标签,概念验证研究.
八周的贝达基林单一治疗,然后是标准的MDT.
主要终点:小鼠脚中Mycobacterium leprae生长的变化.
二级终点:安全性和耐受性.

主要成果:

在4周的贝达基林单一治疗后,Mycobacterium leprae的完全清除.
在7周内,皮肤病变显著改善.
所有不良事件都是轻微的 (1或2级).

结论:

贝达基林单一治疗显示出对Mycobacterium leprae的快速杀菌活性.
随着贝达基林治疗,病症状的早期临床改善得到了观察.
贝达基林作为新,更安全的麻风治疗方案的组成部分,显示出有前途.

更多相关视频

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice

Published on: March 23, 2014

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...